APA (7th ed.) Citation

Symeonidis, A., Kouraklis-Symeonidis, A., Galanopoulos, A., Hatzimichael, E., Zikos, P., Vassilakopoulos, T., . . . Liapi, D. (2017). 123 - Lenalidomide Induces Responses in Patients with MDS-DEL(5)Q Alone, or with One Additional Abnormality, Irrespective of Who Classification and Prognostic Categorization. Leukemia Research, 55, S76. https://doi.org/10.1016/S0145-2126(17)30236-9

Chicago Style (17th ed.) Citation

Symeonidis, A., et al. "123 - Lenalidomide Induces Responses in Patients with MDS-DEL(5)Q Alone, or with One Additional Abnormality, Irrespective of Who Classification and Prognostic Categorization." Leukemia Research 55 (2017): S76. https://doi.org/10.1016/S0145-2126(17)30236-9.

MLA (9th ed.) Citation

Symeonidis, A., et al. "123 - Lenalidomide Induces Responses in Patients with MDS-DEL(5)Q Alone, or with One Additional Abnormality, Irrespective of Who Classification and Prognostic Categorization." Leukemia Research, vol. 55, 2017, p. S76, https://doi.org/10.1016/S0145-2126(17)30236-9.